Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P.

Lysozyme is one of the most abundant antimicrobial proteins in the airspaces of the lung. Mice express two lysozyme genes, lysozyme M and P, but only the M enzyme is detected in abundance in lung tissues. Disruption of the lysozyme M locus significantly increased bacterial burden and mortality following intratracheal infection with a Gram-negative bacterium. Unexpectedly, significant lysozyme enzyme activity (muramidase activity) was detected in the airspaces of uninfected lysozyme M-/- mice, amounting to 25% of the activity in wild-type mice. Muramidase activity in lysozyme M-/- mice was associated with increased lysozyme P mRNA and protein in lung tissue and bronchoalveolar lavage fluid respectively. The muramidase activity of recombinant lysozyme P was less than that of recombinant M lysozyme. Recombinant P lysozyme was also less effective in killing selected Gram-negative bacteria, requiring higher concentrations than lysozyme M to achieve the same level of killing. The lower antimicrobial activity of P lysozyme, coupled with incomplete compensation by P lysozyme in lysozyme M-/- mice, probably accounts for the increased susceptibility of null mice to infection. Recombinant lysozyme M and P were equally effective in killing selected Gram-positive organisms. This outcome suggests that disruption of both M and P loci would significantly increase susceptibility to airway infections, particularly those associated with colonization by Gram-positive organisms.

[1]  T. Korfhagen,et al.  Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. , 2004, American journal of respiratory and critical care medicine.

[2]  T. Graf,et al.  Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. , 2003, Blood.

[3]  H. Ibrahim,et al.  Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model molecules. , 2002, Current pharmaceutical design.

[4]  A. Pellegrini,et al.  A Helix-Loop-Helix Peptide at the Upper Lip of the Active Site Cleft of Lysozyme Confers Potent Antimicrobial Activity with Membrane Permeabilization Action* , 2001, The Journal of Biological Chemistry.

[5]  T Matsuzaki,et al.  Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function , 2001, FEBS letters.

[6]  R. Epaud,et al.  Bacterial Killing Is Enhanced by Expression of Lysozyme in the Lungs of Transgenic Mice1 , 2000, The Journal of Immunology.

[7]  T. Graf,et al.  Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. , 2000, Blood.

[8]  J. Whitsett,et al.  Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[9]  H. Geuze,et al.  Biosynthetic routing of pulmonary surfactant proteins in alveolar type II cells , 1993, Microscopy research and technique.

[10]  J. Power,et al.  Characterization and immunohistochemical localization of the 15 kD protein isolated from rat lung lamellar bodies. , 1993, American journal of respiratory cell and molecular biology.

[11]  M. Montgomery,et al.  Immunocytochemical localization of lysozyme and surfactant protein A in rat type II cells and extracellular surfactant forms. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  A. Wilson,et al.  Recent origin of the P lysozyme gene in mice. , 1990, Nucleic acids research.

[13]  S. Rennard,et al.  Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. , 1990, The Journal of laboratory and clinical medicine.

[14]  R. Mason,et al.  Pulmonary lysozyme--a secretory protein of type II pneumocytes in the rat. , 1988, The American review of respiratory disease.

[15]  R. Renkawitz,et al.  Mouse lysozyme M gene: isolation, characterization, and expression studies. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Laible,et al.  Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides , 1985, Infection and immunity.

[17]  T. Boat,et al.  Human lung lysozyme: sources and properties. , 1981, The American review of respiratory disease.

[18]  Z. Cohn,et al.  IN VITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTES , 1974, The Journal of experimental medicine.